http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2550363-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1e98e4cf0dc95eca2399be2a66c15dd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
| filingDate | 2016-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa2e07241e7d86a152afea2eeb4e6f1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b44b10f9ce81c78145fa1ca243359ccf |
| publicationDate | 2017-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2550363-A |
| titleOfInvention | Compound |
| abstract | Compound according to formula (I) or a salt, ester, solvate, N-oxide, or prodrug thereof, where the substituents are as defined in the claims. Preferably R6 is H, R10 is H, and R2 is a methoxyethoxy substituent. Preferable compounds are 2-(2-methoxyethoxy)-1-(thiazol-2-yl)ethan-1-one and 13-(thiazol-2-yl)-2,5,8,11-tetraoxatridecan-13-one. Compounds according to formula I may be used in therapy, especially in the treatment or prevention of a chronic inflammatory condition or hyperproliferative disorder. Also claimed are compounds according to formula II or a salt, ester, solvate, N-oxide, or prodrug thereof for use in the treatment or prevention of a chronic inflammatory condition or hyperproliferative disorder. |
| priorityDate | 2016-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.